Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Satsuma Pharmaceuticals Inc
(NQ:
STSA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.060 (5)
Ask (Size)
1.100 (5)
Prev. Close
1.100
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
33,152,498
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
June 09, 2023
The Dow Jones closed higher by over 160 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA
May 10, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
More News
Read More
SATSUMA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Satsuma Pharmaceuticals, Inc. - STSA
April 21, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
April 18, 2023
Via
Benzinga
Crude Oil Down 2%; State Street Shares Tumble After Downbeat Results
April 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 17, 2023
Via
Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 17, 2023
Via
Benzinga
Gold Drops Below $2,000; Charles Schwab Earnings Top Views
April 17, 2023
Via
Benzinga
STSA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Satsuma Pharmaceuticals, Inc. Is Fair to Shareholders
April 17, 2023
From
Halper Sadeh LLC
Via
Business Wire
Why Is SAI.TECH Global (SAI) Stock Down 32% Today?
April 17, 2023
Via
InvestorPlace
Why Is Marpai (MRAI) Stock Down 40% Today?
April 17, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 17, 2023
Via
Benzinga
Why Is Prometheus Biosciences (RXDX) Stock Up 70% Today?
April 17, 2023
Via
InvestorPlace
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
April 17, 2023
Via
Benzinga
Why Is Satsuma Pharmaceuticals (STSA) Stock Up 144% Today?
April 17, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 17, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 07, 2023
Via
Benzinga
Why Universal Electronics Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Friday's Mid-Day Session
February 17, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 26, 2022
Via
Benzinga
Despite Trial Failure, Satsuma Pharma Says Its Migraine Candidate Has Potential For Approval
December 20, 2022
Via
Benzinga
Why Elevate Credit Shares Are Trading Higher By Over 71%? Here Are 43 Stocks Moving In Thursday's Mid-Day Session
November 17, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 17, 2022
Via
Benzinga
Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket
November 17, 2022
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Satsuma Pharmaceuticals: Here's What You Need To Know
November 15, 2022
Via
Benzinga
Expert Ratings for Satsuma Pharmaceuticals
November 15, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.